We are live on ! Find out more
AONCW

American Oncology Network, Inc. Warrant
AONCW

Delisted

AONCW was delisted on the 7th of June, 2024.

Back to rankings

32 hedge funds and large institutions have $729K invested in American Oncology Network, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $750K → $729K (-$21.5K)

6% less funds holding

Funds holding: 34 → 32 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
3
Calls
$59K
Puts
–
Net Calls
+$59K
Net Calls Change
-$7K

Top Buyers

Rank Fund Capital Flow
1
KL
KIM LLC
Kansas
+$8.35K
2
CS
Clear Street
New York
+$7.51K
3
WAM
Wolverine Asset Management
Illinois
+$1.4K

Top Sellers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
-$97.1K
2
EFI
EHP Funds Inc
Canada
-$22.3K
3
Walleye Capital
Walleye Capital
New York
-$19K
4
PC
Periscope Capital
Ontario, Canada
-$16.5K
5
SFM
Spartan Fund Management
Canada
-$9.51K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$197K – – –
SCM
2
Shaolin Capital Management
Florida
$69K -$97.1K -465,101 -61%
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$44.6K – – –
Goldman Sachs
4
Goldman Sachs
New York
$42.1K – – –
SBLIC
5
Security Benefit Life Insurance Company
Kansas
$41.5K – – –
Calamos Advisors
6
Calamos Advisors
Illinois
$31.6K – – –
CF
7
Cantor Fitzgerald
New York
$28.8K – – –
SC
8
Sculptor Capital
New York
$28.4K – – –
DKCM
9
Davidson Kempner Capital Management
New York
$25K – – –
Walleye Capital
10
Walleye Capital
New York
$22.2K -$19K -91,044 -45%
EFI
11
EHP Funds Inc
Canada
$21.4K -$22.3K -106,826 -52%
LP
12
LMR Partners
United Kingdom
$20.1K – – –
CS
13
Clear Street
New York
$20K +$7.51K +35,991 +71%
CH
14
CVI Holdings
Delaware
$18K – – –
SRF
15
Silver Rock Financial
California
$14.1K – – –
DCM
16
Dupont Capital Management
Delaware
$12.6K – – –
WAM
17
Wolverine Asset Management
Illinois
$11.2K +$1.4K +6,682 +16%
QGA
18
Q Global Advisors
Texas
$11K – – –
WA
19
Whitebox Advisors
Minnesota
$10.6K – – –
AC
20
Aristeia Capital
Connecticut
$10.2K – – –
VI
21
Vestcor Inc
New Brunswick, Canada
$10K – – –
KL
22
KIM LLC
Kansas
$8.08K +$8.35K +40,000 New
CCM
23
CAAS Capital Management
New York
$7.05K – – –
VAS
24
VR Advisory Services
Cayman Islands
$5.08K – – –
FPA
25
First Pacific Advisors
California
$4.38K – – –
1
2

AONCW Hedge Fund Activity: Q4 2023 in Review

32 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Warrant (AONCW) for Q4 2023, worth a combined $729K — down 2.9% from $750K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AONCW and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 2 added.

The largest buyer was KIM LLC, opening a new position worth an estimated $8.35K. The largest seller was Shaolin Capital Management, cutting an estimated $97.1K.

  • 32 institutional investors held American Oncology Network, Inc. Warrant (AONCW) as of Q4 2023, down from 34 in Q3 2023.
  • Funds reported $729K of American Oncology Network, Inc. Warrant stock for Q4 2023, down 2.9% quarter-over-quarter.
  • 1 fund opened new American Oncology Network, Inc. Warrant positions in Q4 2023 and 3 closed out, a net change of -2 holders.
  • The largest American Oncology Network, Inc. Warrant buyer in Q4 2023 was KIM LLC, an estimated $8.35K added.
  • The largest American Oncology Network, Inc. Warrant seller in Q4 2023 was Shaolin Capital Management, an estimated $97.1K sold.

Based on aggregated 13F filings for Q4 2023.